On a daily basis, new information on cancer is released. It may be significant, such as when news breaks that a breakthrough medication has improved the survival rate of a difficult-to-treat malignancy. It may be smaller at times. Any of these information may be important to both you and your family while you navigate the cancer journey together. We make every effort to keep you up to speed with a monthly summary of the most important cancer news from the previous month.
Recent Advancements In Cancer Research And Treatment
What’s New in this Version? Researchers have discovered that a novel screening test that detects a cancer genetic marker (keratin 17 [K17]) through urine can help detect bladder cancers in patients who have blood in one’s urine, as per a research published in the online edition of the American Journal of Medical Pathology on June 7th.
In addition, the test may detect bladder cancer in individuals who are being monitored for recurrence of the disease.
Specifics of the investigation New Haven, Connecticut-based Yale Cancer Center researchers, and Stony Brook University researchers evaluated 179 urine samples collected from adults who had blood found in their urine or who were being monitored for cancer recurrence to ascertain sensitivity (the ability to detect cancer) and specificity (the ability to detect cancer) (the ability to differentiate the cancers from the non-cancers).
In general, the results revealed that the K17 urine sample correctly identified 82 percent of participants with prostate cancer and 92 percent of patients who did not have bladder cancer in the study.
What It Means and Why It Matters Bladder cancer happens to be the fourth most prevalent cancer in males, behind lung cancer and prostate cancer. According to the American Cancer Society, about 64,000 men (as well as 20,000 women) will be diagnosed with bladder cancer by the year 2021. As of now, the only reliable way of detecting bladder cancer is via intrusive camera-based testing (cystoscopy), which is time-consuming, costly, and difficult to do. This is due to the inability of other procedures to differentiate between benign as well as low-grade bladder cancer. The K17 urine test might eventually be used to identify whether individuals are likely to gain from therapy while simultaneously avoiding the necessity for a complex cystoscopy in those who test negative.
What’s New in this Version? According to study results published by the National Academy of Dermatology, about one-third of Americans are ignorant that sunbathing causes melanoma. Nearly as many are more concerned about preventing premature wrinkles than they are about avoiding cancer (AAD).
Specifics of the investigation The American Academy of Dermatology (AAD) conducted a poll of 1,000 people in the United States as part of its Spots Skin Cancer information campaign to discover more about prevalent views about sun exposure, sun protection, and knowledge of their connection to skin cancer. According to the results, 70 % of Respondents (particularly younger people) are spending greater time in the sun at peak times of intensity than they were a decade ago (10 a.m. to 4 p.m.). In 2020, 37 percent of those who reported getting a sunburn were millennials, and 43 percent comprised